Engraftment of embryonic stem cell-derived myogenic progenitors in a dominant model of muscular dystrophy

Experimental Neurology

Volumn 220, Issue 1, 2009, Pages 212-216

  Darabi, Radbod ^a,b   Baik, June ^a,b   Clee, Mark ^b   Kyba, Michael ^a,b   Tupler, Rossella ^c,d   Perlingeiro, Rita C R ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Dominant disease; Embryonic stem cells; FRG1 mice; Muscle differentiation; Muscular dystrophy; Pax3; Transplantation

Indexed keywords

TACROLIMUS; TRANSCRIPTION FACTOR PAX3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYONIC STEM CELL; ENGRAFTMENT; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FEMALE; GRAFT REJECTION; MALE; MOUSE; MUSCLE CONTRACTILITY; MUSCLE FUNCTION; MUSCLE REGENERATION; NONHUMAN; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; TISSUE SECTION; TRANSGENIC MOUSE;

ANIMALS; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; FEMALE; GENES, DOMINANT; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, TRANSGENIC; MUSCLE DEVELOPMENT; MUSCLE WEAKNESS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; NUCLEAR PROTEINS; PAIRED BOX TRANSCRIPTION FACTORS; REGENERATION; SATELLITE CELLS, SKELETAL MUSCLE; SEX CHARACTERISTICS; STEM CELL TRANSPLANTATION; STEM CELLS; TREATMENT OUTCOME;

EID: 70349741336     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2009.08.002     Document Type: Article

References (24)

1. Brussee V., Tardif F., Roy B., Goulet M., Sebille A., and Tremblay J.P. Successful myoblast transplantation in fibrotic muscles: no increased impairment by the connective tissue. Transplantation 67 (1999) 1618-1622
2. Cerletti M., Jurga S., Witczak C.A., Hirshman M.F., Shadrach J.L., Goodyear L.J., and Wagers A.J. Highly efficient, functional engraftment of skeletal muscle stem cells in dystrophic muscles. Cell 134 (2008) 37-47
3. Clark B.C., Manini T.M., The D.J., Doldo N.A., and Ploutz-Snyder L.L. Gender differences in skeletal muscle fatigability are related to contraction type and EMG spectral compression. J. Appl. Physiol. 94 (2003) 2263-2272
4. Collins C.A., Olsen I., Zammit P.S., Heslop L., Petrie A., Partridge T.A., and Morgan J.E. Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell 122 (2005) 289-301
5. D'Antona G., Brocca L., Pansarasa O., Rinaldi C., Tupler R., and Bottinelli R. Structural and functional alterations of muscle fibres in the novel mouse model of facioscapulohumeral muscular dystrophy. J. Physiol. 584 (2007) 997-1009
6. Darabi R., Gehlbach K., Bachoo R.M., Kamath S., Osawa M., Kamm K.E., Kyba M., and Perlingeiro R.C. Functional skeletal muscle regeneration from differentiating embryonic stem cells. Nat. Med. 14 (2008) 134-143
7. Deasy B.M., Lu A., Tebbets J.C., Feduska J.M., Schugar R.C., Pollett J.B., Sun B., Urish K.L., Gharaibeh B.M., Cao B., Rubin R.T., and Huard J. A role for cell sex in stem cell-mediated skeletal muscle regeneration: female cells have higher muscle regeneration efficiency. J. Cell. Biol. 177 (2007) 73-86
8. Deconinck A.E., Rafael J.A., Skinner J.A., Brown S.C., Potter A.C., Metzinger L., Watt D.J., Dickson J.G., Tinsley J.M., and Davies K.E. Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell 90 (1997) 717-727
9. Emery A.E. The muscular dystrophies. Lancet 359 (2002) 687-695
10. Gabellini D., D'Antona G., Moggio M., Prelle A., Zecca C., Adami R., Angeletti B., Ciscato P., Pellegrino M.A., Bottinelli R., Green M.R., and Tupler R. Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1. Nature 439 (2006) 973-977
11. Glenmark B., Nilsson M., Gao H., Gustafsson J.A., Dahlman-Wright K., and Westerblad H. Difference in skeletal muscle function in males vs. females: role of estrogen receptor-beta. Am. J. Physiol., Endocrinol. Metab. 287 (2004) E1125-1131
12. Grady R.M., Teng H., Nichol M.C., Cunningham J.C., Wilkinson R.S., and Sanes J.R. Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell 90 (1997) 729-738
13. Gussoni E., Blau H.M., and Kunkel L.M. The fate of individual myoblasts after transplantation into muscles of DMD patients. Nat. Med. 3 (1997) 970-977
14. Havenith M.G., Visser R., Schrijvers-van Schendel J.M., and Bosman F.T. Muscle fiber typing in routinely processed skeletal muscle with monoclonal antibodies. Histochemistry 93 (1990) 497-499
15. Mendell J.R., Kissel J.T., Amato A.A., King W., Signore L., Prior T.W., Sahenk Z., Benson S., McAndrew P.E., Rice R., et al. Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N. Engl. J. Med. 333 (1995) 832-838
16. Montarras D., Morgan J., Collins C., Relaix F., Zaffran S., Cumano A., Partridge T., and Buckingham M. Direct isolation of satellite cells for skeletal muscle regeneration. Science 309 (2005) 2064-2067
17. Paljärvi L., and Naukkarinen A. Histochemical method for simultaneous fiber typing and demonstration of capillaries in skeletal muscle. Histochemistry 93 (1990) 385-387
18. Partridge T.A., Morgan J.E., Coulton G.R., Hoffman E.P., and Kunkel L.M. Conversion of mdx myofibers from dystrophin-negative to positive by injection of normal myoblasts. Nature 337 (1989) 176-179
19. Sampaolesi M., Torrente Y., Innocenzi A., Tonlorenzi R., D'Antona G., Pellegrino M.A., Barresi R., Bresolin N., De Angelis M.G., Campbell K.P., Bottinelli R., and Cossu G. Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts. Science 301 (2003) 487-492
20. Sampaolesi M., Blot S., D'Antona G., Granger N., Tonlorenzi R., Innocenzi A., Mognol P., Thibaud J.L., Galvez B.G., Barthélémy I., Perani L., Mantero S., Guttinger M., Pansarasa O., Rinaldi C., De Angelis M.G.C., Torrente Y., Bordignon C., Bottinelli R., and Cossu G. Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 444 (2006) 574-579
21. Tremblay J.P., Malouin F., Roy R., Huard J., Bouchard J.P., Satoh A., and Richards C.L. Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transplant. 2 (1993) 99-112
22. Vilquin J.T. Myoblast transplantation: clinical trials and perspectives. Acta Myol. 24 (2005) 119-127
23. Watt D.J., Lambert K., Morgan J.E., Partridge T.A., and Sloper J.C. Incorporation of donor muscle precursor cells into an area of muscle regeneration in the host mouse. J. Neurol. Sci. 57 (1982) 319-331
24. Watt D.J., Morgan J.E., and Partridge T.A. Use of mononuclear precursor cells to insert allogeneic genes into growing mouse muscles. Muscle Nerve 7 (1984) 741-750